Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25144
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkpolat, Tekin-
dc.contributor.authorDiri, Banu-
dc.contributor.authorOǧuz, Yusuf-
dc.contributor.authorYılmaz, Emine Demirel-
dc.contributor.authorDilek, Melda-
dc.date.accessioned2022-03-17T12:05:16Z-
dc.date.available2022-03-17T12:05:16Z-
dc.date.issued2003-05-
dc.identifier.citationAkpolat, T. vd. (2003). “Behcet's disease and renal failure”. Nephrology Dialysis Transplantation, 18(5), 888-891.en_US
dc.identifier.issn0931-0509-
dc.identifier.urihttps://doi.org/10.1093/ndt/gfg084-
dc.identifier.urihttps://academic.oup.com/ndt/article/18/5/888/1833151-
dc.identifier.urihttp://hdl.handle.net/11452/25144-
dc.description.abstractBackground. The aims of this study were (i) to investigate the prevalence of Behcet's disease (BD) among dialysis patients in Turkey, (ii) to report the clinical characteristics of patients with BD and endstage renal disease (ESRD), (iii) to evaluate the effect of ESRD on course and activity of BD and (iv) to analyse the published data about BD and renal failure. Methods. A questionnaire investigating BD among dialysis patients was submitted to 350 dialysis centres and we obtained the data for 20 596 patients from 331 dialysis centres. We submitted a second questionnaire regarding clinical characteristics of the patients with BD and ESRD. The PubMed and Web of Science databases were used for the analysis of BD and renal failure. Results. Fourteen patients with BD were determined and the prevalence of BD was 0.07% among 20 596 dialysis patients in Turkey. None of the patients has had a new manifestation of BD after initiation of haemodialysis treatment. The analysis of previous data about renal BD demonstrated 67 patients with renal failure. Conclusions. The most common cause of renal failure in BD is amyloidosis. Routine urine analysis and measurement of serum creatinine and blood urea nitrogen levels are needed for early diagnosis. Vascular access-related problems are common and the activity of BD appears to decrease in patients with ESRD after initiation of haemodialysis.en_US
dc.language.isoenen_US
dc.publisherOxford Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectTransplantationen_US
dc.subjectUrology and nephrologyen_US
dc.subjectAmyloidosisen_US
dc.subjectBehçet's diseaseen_US
dc.subjectCyclosporinen_US
dc.subjectGlomerulonephritisen_US
dc.subjectRenal failureen_US
dc.subjectHemolytic-uremic syndromeen_US
dc.subjectCyclosporine-Aen_US
dc.subjectTherapyen_US
dc.subject.meshAdulten_US
dc.subject.meshAmyloidosisen_US
dc.subject.meshBehcet Syndromeen_US
dc.subject.meshCatheters, indwellingen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney failure, chronicen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshQuestionnairesen_US
dc.subject.meshRenal dialysisen_US
dc.subject.meshTurkeyen_US
dc.titleBehcet's disease and renal failureen_US
dc.typeArticleen_US
dc.identifier.wos000182732700011tr_TR
dc.identifier.scopus2-s2.0-0038363758tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.tr_TR
dc.identifier.startpage888tr_TR
dc.identifier.endpage891tr_TR
dc.identifier.volume18tr_TR
dc.identifier.issue5tr_TR
dc.relation.journalNephrology Dialysis Transplantationen_US
dc.contributor.buuauthorYavuz, Mahmut-
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed12686660tr_TR
dc.subject.wosTransplantationen_US
dc.subject.wosUrology and nephrologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2 (Transplantation)en_US
dc.wos.quartileQ1 (Urology & nephrology)en_US
dc.contributor.scopusid7006244754tr_TR
dc.subject.scopusBehcet Syndrome; Glomerulonephritis; Vasculitisen_US
dc.subject.emtreeColchicineen_US
dc.subject.emtreeCreatinineen_US
dc.subject.emtreeCyclosporinen_US
dc.subject.emtreeSteroiden_US
dc.subject.emtreeUreaen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAmyloidosisen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBehcet diseaseen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCreatinine blood levelen_US
dc.subject.emtreeData analysisen_US
dc.subject.emtreeDisease activityen_US
dc.subject.emtreeDisease courseen_US
dc.subject.emtreeHemodialysis patienten_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney failureen_US
dc.subject.emtreeMedical literatureen_US
dc.subject.emtreeMedlineen_US
dc.subject.emtreePrevalenceen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePublicationen_US
dc.subject.emtreeQuestionnaireen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeUrea nitrogen blood levelen_US
dc.subject.emtreeUrinalysisen_US
dc.subject.emtreeVascular accessen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Yavuz_vd_2003.pdf91.18 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons